Physician profile
Steven Binenbaum
NPI 1366628281
$23,591.74
in general payments reported to CMS, 2019-2025
23 companies · $3,790 in 2025
The $3,790 reported for 2025 was more than what 88% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,033 · 2020: $2,925 · 2021: $2,205 · 2022: $2,244 · 2023: $2,135 · 2024: $2,259 · 2025: $3,790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,337 · Travel and Lodging: $3,296 · Education: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,337.16 |
| Travel and Lodging | $3,295.83 |
| Education | $551.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $9,076.01 | 2019-2025 | Gore Synecor Biomaterial, Seamguard, Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Miromatrix Medical INC. | $2,614.00 | 2019 | |
| Stryker Corporation | $2,509.46 | 2021-2025 | 1788 |
| Intuitive Surgical, INC. | $2,282.29 | 2019-2025 | |
| Asensus Surgical, INC. | $1,293.04 | 2019 | |
| Tela Bio, INC. | $1,059.71 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Medical Device Business Services, INC. | $1,039.02 | 2019 | |
| Medtronic, INC. | $735.24 | 2022-2024 | Endoflip, Signia, Absorbatack |
| Ethicon US, LLC | $720.57 | 2019-2023 | Echelon Flex |
| Davol INC. | $383.26 | 2021-2024 | Phasix Mesh |
| Covidien Lp | $268.92 | 2019 | |
| Standard Bariatrics, INC. | $250.00 | 2019 | |
| Ambu INC. | $220.12 | 2025 | |
| Teleflex LLC | $199.09 | 2023 | Weck |
| Integra Lifesciences Corporation | $180.91 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $174.76 | 2022-2025 | Aponvie |
| Baxter Healthcare | $174.36 | 2020-2024 | Floseal, Tisseel |
| Dilon Technologies, INC. | $139.10 | 2024 | Hemoblast Bellows |
| Fujifilm Healthcare Americas Corporation | $96.59 | 2019-2020 | |
| Kerecis Limited | $92.54 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Novo Nordisk INC | $36.12 | 2021 | |
| Endo Pharmaceuticals INC. | $26.63 | 2019 | |
| Allergan, INC. | $20.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Binenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.